Keep unapproved drugs out of patients? hands AAP News (subscription) - 16 minutes ago Unapproved Drugs: Drugs Marketed in the United States That Do Not Have Required FDA Approval is a Web site that provides tailored information to health care ...
FDA Struggling To Weed Out Unapproved Drugs Pharmaceutical Online (press release), PA - Nov 26, 2008 The FDA estimates that unapproved drugs account for 2 percent of all prescriptions filled by US pharmacies, about 72 million prescriptions a year. ...
Panel seeks warning on facial filler risks El Paso Times, TX - But a recent FDA hearing raised questions about unapproved uses, untrained technicians giving injections, and a lack of data on long-term safety. ...
FDA Warns Bayer about Marketing Unapproved Drugs Pharmaceutical Technology Magazine, NJ - Nov 6, 2008 FDA says the products are unapproved new drugs that require approved new drug applications to be legally marketed. The drugs? labels list uses that the ...
Study Calls for Greater Scrutiny of 'Off-Label' Drug Use U.S. News & World Report, DC - Nov 24, 2008 Despite the scope of the practice, there's often little evidence that using a drug for an unapproved purpose is always beneficial or safe, a new study found ...
Source: Google News
Recent News and Articles on the Keywords: unapproved + drugs + fda Related to the article below (Last Update: 8/7/2008)
The FDA's Black Box Forbes, NY - 48 minutes ago As a matter of law, the FDA must keep communications about unapproved drugs confidential. That silence reflects larger ways in which the agency is having ...SGP - OTC:SHRGY
Toxic Drugs, Toxic System: Sociologist Predicts Drug Disasters Science Daily (press release) - Aug 4, 2008 5, 2008) ? Americans are likely to be exposed to unacceptable side effects of FDA-approved drugs such as Vioxx in the future because of fatal flaws in the ...
Federal Agents Seize Over $24 Million in Unapproved Drugs Newsinferno.com, NY - Jul 31, 2008 US Food and Drug Administration (FDA) and US Marshals Service representatives just seized $24.2 million worth of unapproved drugs from KV Pharmaceutical ...KV.A
US Congress slams FDA for off-label promotion control failures Pharma Times (subscription), UK - Aug 4, 2008 Sheer volume prevents the FDA from reviewing all the promotional materials which are submitted to it by drug companies, so it prioritises its reviews in ...
FDA faulted over unapproved uses of medications The Associated Press - Jul 27, 2008 Also, under guidance proposed by the FDA this year, drug companies could distribute to doctors scientific articles that suggest new and unapproved uses for ...
Dietary supplement or drug? The case of Cholestin - RJ Havel - American Journal of Clinical Nutrition, 1999 - Am Soc Nutrition ...FDA determines Cholestin to be an unapproveddrug. ... Elchisak MA, ed. Cholestin determined
to be unapproveddrug by FDA 05/20/98. Drugs in the news: 1998 index. ...
Illegal use of beta-adrenergic agonists in the United States - GA Mitchell, G Dunnavan - Journal of Animal Science, 1998 - Am Soc Animal Sci ... pounds of products containing unapproveddrugs, valued at ... premix containing these
illegal and harmful animal drugs. ... Attorneys Office, US Customs, FDA, and USDA ...
DrugBank: a comprehensive resource for in silico drug discovery and exploration - DS Wishart, C Knox, AC Guo, S Shrivastava, M … - Nucleic Acids Research - Oxford Univ Press ... small molecule drugs (>700 entries), (ii) FDA-approved biotech (protein ... 60 entries)
and (iv) experimental drugs, including unapproveddrugs, de-listed ...
- JO'Reilly, A Dalal - Annals Health L., 2003 - HeinOnline Prescriber and Marketer Liability for Unapproved Uses of FDA-Approved Drugs James
O'Reilly' and Amy Dalal2 I. INTRODUCTION The year 2003 marks four decades ...
Internet Purchase of Prescription Drugs: Buyer Beware - JE Henney, JE Shuren, SL Nightingale, TJ McGinnis - Annals of Internal Medicine, 1999 - annals.highwire.org ... an appropriate, Food and Drug Administration (FDA)-approved drug. ... medications, dangerous drug interactions, contaminated drugs, or unapproveddrugs that may ...
Benefit vs. Risk: How FDA Approves New Drugs. D Farley - FDA Consumer, 1987 - questia.com ... before. Promising is the key word in this broadened use of unapproveddrugs. FDA can't allow drugs to be used haphazardly. "It's ...
[CITATION] A New Era of Unapproved Drugs: The Case of Abigail Alliance v Von Eschenbach - PD Jacobson, WE Parmet - JAMA: The Journal of the American Medical Association, 2007 - JAMA ... should reject a constitutional right to unapproveddrugs and give more weight to
the important public health interests served by the FDA's regulatory process. ...
FDA tells 3 companies to stop making unapproved drugs
U.S. authorities said on Thursday they told three companies to stop mass-producing and distributing unapproved medicines to treat asthma, bronchitis and other breathing disorders.
The Food and Drug Administration said the companies sold thousands of doses of inhaled drugs nationwide. The companies argued they were working under a practice known as "compounding" in which pharmacists customize formulations for specific patients, the FDA said.
The FDA allows compounding if a doctor prescribes something that meets a medical need and is unavailable in an approved product. A pharmacist, for example, could crush a tablet and mix it into a liquid for someone with trouble swallowing pills, or provide a version without a preservative that could cause an allergic reaction.
The three companies - Rotech Healthcare Inc, CCS Medical and Reliant Pharmacy Services - produced large quantities of unapproved drugs that did not provide benefits over approved medicines, the FDA said.
Joe Grillo, a spokesman for Reliant's parent Lincare Inc., said the company had no comment. Officials at Rotech and CCS Medical did not immediately return calls seeking comment.
The FDA said the products were inhaled drugs for treating asthma, emphysema, bronchitis and cystic fibrosis. Each of the conditions has FDA-approved treatments.
The medicines were distributed through mail order, Web sites and companies that sold devices used to inhale the medicines, said Steve Silverman, acting assistant director of compliance in the FDA's Center for Drug Evaluation and Research.
Officials urged patients to talk with their doctors and pharmacists to make sure they did not unknowingly receive some of the unapproved products.
"Compounded inhalation drugs are not reviewed by the FDA for safety and effectiveness, often are not produced according to good drug manufacturing practice, and typically are not sterile. This may expose patients to unnecessary risk," Dr. Steven Galson, director of the FDA's Center for Drug Evaluation and Research, said in a statement.
